Physician profile
Michael L Gordon
NPI 1073541819
$7,917.59
in general payments reported to CMS, 2019-2025
37 companies · $2,600 in 2025
The $2,600 reported for 2025 was more than what 92% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $966 · 2020: $299 · 2021: $846 · 2022: $694 · 2023: $1,140 · 2024: $1,373 · 2025: $2,600.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,112.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,784.25 | 2019-2025 | Augment Injectable, Hoffmann, Hydroset |
| Trimed, INC. | $1,101.67 | 2025 | |
| Paratek Pharmaceuticals, INC. | $754.96 | 2021-2025 | Nuzyra |
| Bone Support INC. | $230.23 | 2021 | |
| Zimmer Biomet Holdings, INC. | $202.23 | 2019 | |
| Acera Surgical, INC. | $191.14 | 2024 | Restrata Wound Matrix |
| Organogenesis INC. | $174.55 | 2019-2025 | Nushield, Affinity |
| Smith+Nephew, INC. | $140.16 | 2020-2025 | Renasys Touch, Collagenase Santyl |
| Nevro Corp. | $137.91 | 2023 | Senza |
| Treace Medical Concepts, INC. | $121.19 | 2022-2025 | |
| Horizon Therapeutics Plc | $114.87 | 2023 | Krystexxa |
| Averitas Pharma INC. | $105.12 | 2023-2025 | Qutenza |
| Medinc of Texas | $81.15 | 2025 | |
| Reddress USA, INC. | $80.06 | 2024 | |
| Tactile Systems Technology INC | $70.09 | 2020-2024 | Entre Plus, Flexitouch Plus |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $67.46 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Alafair Biosciences, INC. | $66.15 | 2024 | Versawrap |
| Abbott Laboratories | $54.33 | 2022-2024 | Eterna, Octrode |
| Amgen INC. | $49.90 | 2024-2025 | Krystexxa |
| Polynovo North America LLC | $31.13 | 2025 | Novosorb Btm |
| Imbed Biosciences INC. | $30.00 | 2022 | |
| Misonix INC | $29.77 | 2019 | |
| Abbvie INC. | $28.77 | 2023 | |
| Medtronic, INC. | $27.59 | 2025 | Inceptiv |
| Lifenet Health | $26.94 | 2025 | Theragenesis Wound Matrix |
| Dynasplint Systems INC. | $22.74 | 2019 | |
| Osiris Therapeutics INC. | $20.87 | 2019 | |
| Kerecis Limited | $19.99 | 2021 | |
| Innovation Technologies INC | $19.32 | 2024 | Irrisept |
| Davol INC. | $18.87 | 2022 | |
| Convatec INC. | $18.65 | 2021 | |
| Integra Lifesciences Corporation | $18.04 | 2025 | Integra |
| Mimedx Group, INC. | $17.83 | 2024 | |
| Inari Medical, INC. | $17.53 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Triad Life Sciences INC. | $17.44 | 2022 | |
| Reprise Biomedical, INC. | $13.68 | 2025 | Miro3d |
| Merck Sharp & Dohme LLC | $11.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gordon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.